Ali J. Satvat
CIK 1621788 · View on SEC EDGAR ↗
First SEC filing: June 9, 2026 · Latest: June 9, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 22, 2026 | BBIO | A | 5,277 | — | — | 5,277 Direct | — | Acquired | (price as of 2026-08-20) |
| June 22, 2026 | BBIO | A | 3,990 | — | — | 169,983 Direct | +2.40% | Acquired | (price as of 2026-08-20) |
| June 5, 2026 | CHRS | A | 30,000 | — | — | 30,000 | — | — | (price as of 2026-08-20) |
| June 20, 2025 | BBIO | A | 8,425 | — | — | 8,425 Direct | — | Acquired | (price as of 2026-08-20) |
| June 20, 2025 | BBIO | A | 6,589 | — | — | 165,993 Direct | +4.13% | Acquired | (price as of 2026-08-20) |
| Dec. 30, 2024 | BBIO | M | 39,851 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-20) |
| Dec. 30, 2024 | BBIO | M | 39,851 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-20) |
| Dec. 30, 2024 | BBIO | M | 79,702 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-20) |
| Dec. 30, 2024 | BBIO | M | 39,851 | $26.21 | $1,044,495 | 159,404 Direct | +33.33% | Acquired | 217.6% (price as of 2026-08-20) |
| Dec. 30, 2024 | BBIO | M | 39,851 | $16.68 | $664,715 | 119,553 Direct | +50.00% | Acquired | 399.1% (price as of 2026-08-20) |
| Dec. 30, 2024 | BBIO | M | 79,702 | $10.99 | $875,925 | 79,702 Direct | — | Acquired | 657.6% (price as of 2026-08-20) |
| June 21, 2024 | BBIO | A | 26,014 | — | — | 26,014 Direct | — | Acquired | (price as of 2026-08-20) |
| June 21, 2023 | BBIO | A | 51,501 | — | — | 51,501 Direct | — | Acquired | (price as of 2026-08-20) |
| June 22, 2022 | BBIO | A | 104,921 | — | — | 104,921 Direct | — | Acquired | (price as of 2026-08-20) |
| June 17, 2021 | BBIO | A | 38,895 | — | — | 38,895 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 26, 2021 | BBIO | A | 79,702 | — | — | 79,702 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 26, 2021 | BBIO | A | 39,851 | — | — | 39,851 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 26, 2021 | BBIO | A | 39,851 | — | — | 39,851 Direct | — | Acquired | (price as of 2026-08-20) |
| June 2, 2020 | BBIO | A | 112,422 | — | — | 112,422 Direct | — | Acquired | (price as of 2026-08-20) |
| Dec. 12, 2019 | BBIO | A | 82,878 | — | — | 82,878 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 11, 2019 | CHRS | A | 20,000 | — | — | 20,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Feb. 1, 2018 | CHRS | A | 20,000 | — | — | 20,000 Direct | — | Acquired | (price as of 2026-08-20) |
| May 17, 2017 | CHRS | A | 20,000 | — | — | 20,000 Direct | — | Acquired | (price as of 2026-08-20) |
| May 24, 2016 | CHRS | A | 10,000 | — | — | 10,000 Direct | — | Acquired | (price as of 2026-08-20) |
| April 1, 2015 | CHRS | A | 20,000 | — | — | 20,000 Direct | — | Acquired | (price as of 2026-08-20) |
| April 1, 2015 | CHRS | A | 20,000 | — | — | 20,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Dec. 31, 2014 | CHRS | A | 15,000 | — | — | 15,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Nov. 6, 2014 | CHRS | A | 14,997 | — | — | 14,997 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 22, 2026 | BBIO | Stock Option (Right to Buy) | Common Stock (5,277) | $68.92 | June 21, 2036 | 5,277 | Acquired |
| June 20, 2025 | BBIO | Stock Option (Right to Buy) | Common Stock (8,425) | $41.73 | June 19, 2035 | 8,425 | Acquired |
| Dec. 30, 2024 | BBIO | Stock Option (Right to Buy) | Common Stock (39,851) | $26.21 | May 27, 2030 | 39,851 | Disposed |
| Dec. 30, 2024 | BBIO | Stock Option (Right to Buy) | Common Stock (39,851) | $16.68 | June 12, 2029 | 39,851 | Disposed |
| Dec. 30, 2024 | BBIO | Stock Option (Right to Buy) | Common Stock (79,702) | $10.99 | July 1, 2028 | 79,702 | Disposed |
| June 21, 2024 | BBIO | Stock Option (Right to Buy) | Common Stock (26,014) | $27.36 | June 20, 2034 | 26,014 | Acquired |
| June 21, 2023 | BBIO | Stock Option (right to buy) | Common Stock (51,501) | $16.75 | June 21, 2033 | 51,501 | Acquired |
| June 22, 2022 | BBIO | Stock Option (right to buy) | Common Stock (104,921) | $8.45 | June 22, 2032 | 104,921 | Acquired |
| June 17, 2021 | BBIO | Stock Option (right to buy) | Common Stock (38,895) | $62.63 | June 16, 2031 | 38,895 | Acquired |
| Jan. 26, 2021 | BBIO | Stock Option (Right to Buy) | Common Stock (79,702) | $10.99 | July 1, 2028 | 79,702 | Acquired |
| Jan. 26, 2021 | BBIO | Stock Option (Right to Buy) | Common Stock (39,851) | $16.68 | June 12, 2029 | 39,851 | Acquired |
| Jan. 26, 2021 | BBIO | Stock Option (Right to Buy) | Common Stock (39,851) | $26.21 | May 27, 2030 | 39,851 | Acquired |
| June 2, 2020 | BBIO | Stock Option (right to buy) | Common Stock (112,422) | $29.00 | June 1, 2030 | 112,422 | Acquired |
| Dec. 12, 2019 | BBIO | Stock Option (right to buy) | Common Stock (82,878) | $37.45 | Dec. 11, 2029 | 82,878 | Acquired |
| Jan. 11, 2019 | CHRS | Stock Option (Right to Buy) | Common Stock (20,000) | $12.37 | Jan. 11, 2029 | 20,000 | Acquired |
| Feb. 1, 2018 | CHRS | Stock Option (Right to Buy) | Common Stock (20,000) | $10.05 | Feb. 1, 2028 | 20,000 | Acquired |
| May 17, 2017 | CHRS | Stock Option (Right to Buy) | Common Stock (20,000) | $23.80 | May 17, 2027 | 20,000 | Acquired |
| May 24, 2016 | CHRS | Stock Option (Right to Buy) | Common Stock (10,000) | $18.28 | May 24, 2026 | 10,000 | Acquired |
| April 1, 2015 | CHRS | Stock Option (Right to Buy) | Common Stock (20,000) | $29.00 | March 31, 2025 | 20,000 | Acquired |
| April 1, 2015 | CHRS | Stock Option (Right to Buy) | Common Stock (20,000) | $29.00 | March 31, 2025 | 20,000 | Acquired |
| Dec. 31, 2014 | CHRS | Stock Option (Right to Buy) | Common Stock (15,000) | $16.32 | Dec. 30, 2024 | 15,000 | Acquired |
| Nov. 6, 2014 | CHRS | Stock Option (Right to Buy) | Common Stock (14,997) | $13.50 | Nov. 5, 2024 | 14,997 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).